Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,812,141 papers from all fields of science
Search
Sign In
Create Free Account
HR-756
Known as:
HR 756
, HR756
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Cefotaxime
Cefotaxime Sodium
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
In Vitro Activity of LY 127935 , a New 1-Oxa Cephalosporin , Against Aerobic Gram-Negative Bacilli
D. G. Delgado
,
C. J. Brau
,
C. Cobbs
,
W. Dismukes
2003
Corpus ID: 1835774
A total of 434 clinical aerobic gram-negative bacillary isolates were tested against LY127935, a new 1-oxa cephalosporin, and…
Expand
1981
1981
Clinical experience with cefotaxime (HR-756) in surgical patients.
J. Aznar
,
E. Muñoz
,
M. García-Iglesias
,
E. Perea
Methods and Findings in Experimental and Clinical…
1981
Corpus ID: 28307025
Twenty adult surgical patients aged between 15 and 83 years (mean:45), 10 of whom had wound infections (one complicated with…
Expand
1980
1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin
R. Jones
,
P. Fuchs
,
H. Sommers
,
T. Gavan
,
A. Barry
,
E. Gerlach
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 40158803
Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of…
Expand
1980
1980
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli
J. Jorgensen
,
S. Crawford
,
G. Alexander
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 99409
The in vitro activities of two new beta-lactam antibiotics, moxalactam disodium (LY 127935) and cefotaxime (HR-756), were…
Expand
1980
1980
Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
N. Legakis
,
D. Kafetzis
,
C. Papadatos
,
J. Papavassiliou
Chemotherapy
1980
Corpus ID: 3303921
The in vitro antibacterial activity of HR-756 compared to cefoxitin and cefuroxime. 122 multiresistant clinical isolates…
Expand
1980
1980
Interstitial concentration of antibiotics and their significance for an adequate dosage
Priv.-Doz. Dr. H. -U. Eickenberg
Infection
1980
Corpus ID: 24720786
SummaryThe pharmacokinetic characteristics of the parenteral cephalosporins cephalothin, cefazolin, cephradine, cefamandole…
Expand
1979
1979
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics
R. Wise
,
J. Andrews
,
K. Bedford
Antimicrobial Agents and Chemotherapy
1979
Corpus ID: 43157196
The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal…
Expand
1979
1979
In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli
D. G. Delgado
,
C. J. Brau
,
C. Cobbs
,
W. Dismukes
Antimicrobial Agents and Chemotherapy
1979
Corpus ID: 26526473
A total of 434 clinical aerobic gram-negative bacillary isolates were tested against LY127935, a new 1-oxa cephalosporin, and…
Expand
1979
1979
Comparative activities of cefotaxime, a new cephalosporin derivative, and of selected beta-lactam antibiotics against Haemophilus species.
H. Dabernat
,
A. Buu-Hoï-Dang Van
,
C. Delmas
,
R. Bauriaud
Annals of Microbiology
1979
Corpus ID: 38340924
The activity of cefotaxime (HR756), a new semi-synthetic cephalosporin, was compared with the activity of ampicillin…
Expand
Highly Cited
1978
Highly Cited
1978
Comparison of the In Vitro Activities of HR756 with Cephalothin, Cefoxitin, and Cefamandole
Jacob P. Sosna
,
P. Murray
,
G. Medoff
Antimicrobial Agents and Chemotherapy
1978
Corpus ID: 22561764
The in vitro activity of HR756, a new semisynthetic cephalosporin, was compared with the activities of cephalothin, cefoxitin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE